Statistics from Altmetric.com
A 46 year old white man was referred to us because of an 8 week history of severe progressive headache and psychosis. Associated symptoms were minor somnolence, poor concentration, and weight loss of 10 kg in 3 months. No photosensitivity, fever, or night sweats were reported. Neurological examination was unremarkable. Also, general examination failed to show any abnormality. Especially, no skin abnormalities were apparent. Medical history disclosed an undocumented period of polyarthritis, and for 1 year he had been receiving acenocoumarol because of diagnosed amaurosis fugax.
Laboratory investigation showed a raised erythrocyte sedimentation rate (30 mm/1st h) with a normal C reactive protein and no signs of anaemia or thrombocytopenia. Leucocyte count was normal with slightly decreased lymphocytes (1.9×109/l). An antinuclear antibody (ANA) test was positive with a homogeneous pattern. A positive Crithidia test confirmed the presence of anti-dsDNA antibodies. Low avidity antibodies to dsDNA were detected (43 U/ml). IgM and IgG antibodies to cardiolipin could be demonstrated. The test for lupus anticoagulants was positive. Both lues serology and HIV test were negative. There were no signs of renal or liver disease. Lumbar puncture showed 115×106 leucocytes/l, containing 95% lymphocytes. The protein content of the cerebrospinal fluid (CSF) was raised (5 g/l) with an increased IgG index (1.06) without oligoclonal bands. Antineuronal and antiribosomal P-peptide antibodies were negative in serum and CSF. Cytological analysis of CSF and also polymerase chain reaction for mycobacterial infections showed no abnormalities. Chest x ray and cardiac ultrasound examinations were normal. Brain magnetic resonance imaging (MRI) showed an increased signal intensity on T2 weighted images in the bilateral white matter and in the basal ganglia, which were progressive on repeat MRI (fig 1). Meningeal involvement could not be seen after contrast administration. Cerebral angiography was normal. Brain biopsy showed vasculitis with mononuclear cells, mainly lymphocytes, infiltrating the whole vessel wall, accompanied by fibrinoid necrosis and deposition of IgG and complement in several vessels (fig 2). The diagnosis was neuropsychiatric systemic lupus erythematosus (NPSLE) due to cerebral vasculitis.
Treatment consisting of intravenous methylprednisolone (3 days, 1 g/day), cyclophosphamide monthly (750 mg/m2), and haloperidol resulted in an impressive and sustained clinical and radiological improvement after 6–8 weeks (fig 1). As evaluated by a psychiatrist and a neurologist, he no longer had psychosis, and his severe headache was relieved. He received another two methylprednisolone pulses at weeks 3 and 7 after starting treatment while continuing to receive prednisone 20 mg/day by mouth. Cyclophosphamide pulses will be repeated monthly for 6 months and then every 3 months until he completes 2 years of treatment.
This patient had cerebral vasculitis as a primary manifestation of NPSLE based on psychosis, an earlier episode of polyarthritis, histopathological findings, positive ANAs, anti-dsDNA antibodies, and antiphospholipid antibodies (aPLs). Active SLE as reflected by systemic organ involvement was notably absent, which made a differential diagnosis with other cerebrovascular events appropriate. This patient is a middle age man who was receiving acenocoumarol because of amaurosis fugax and had low titres of ANAs and anti-dsDNA, all of which is compatible with a low risk profile to develop (NP)SLE. Therefore, we performed a brain biopsy, which clearly demonstrated vasculitis. Cerebral vasculitis in SLE is rare and its incidence in postmortem studies does not reach 10%.1–3 Various pathological mechanisms like ischaemic and haemorrhagic events, white matter abnormalities due to aPLs, accelerated atherosclerosis, small vessel vasculopathy, and thromboembolic processes can all play a part. Based on previous studies, it might be argued that aPLs had a role in direct neuronal damage and in the pathogenesis of endothelitis in this patient, although this has not been proved.4,5 Cross reactivity between a subset of anti-DNA antibodies with N-methyl-d-aspartate type receptors in SLE supports the notion of shared antigenic target hypothesis as a possible underlying mechanism.6
No “gold standard” diagnostic test is available at present. Various attempts to link the pathogenesis with sensitive and specific tests have failed so far. Serum or CSF markers to detect NPSLE are lacking. MRI findings correlate with clinical manifestations only with a moderate sensitivity. Angiography may be normal if predominantly small vessels are affected. A recent European survey showed a high degree of perceived attention for cerebral angiography as a diagnostic tool for cerebral vasculitis.7 This patient clearly demonstrates that a normal angiograph cannot rule out fulminate cerebral vasculitis. Despite the low risk of complication, a brain biopsy is usually not needed unless primary cerebral vasculitis is suspected. However, a combination of clinical, serological, and imaging data usually has sufficient diagnostic value and can be used to make the diagnosis in order to institute adequate immunosuppressive treatment.8,9,10 This case report demonstrates that cerebral vasculitis as demonstrated by brain biopsy is a primary and early manifestation of NPSLE.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.